| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $592.2M | +40.0% |
| SG&A Expense | $97.3M | +28.7% |
| Operating Income | -$689.5M | -41.5% |
| Pre-tax Income | -$600.8M | -36.6% |
| Income Tax | -$753K | +78.6% |
| Net Income | -$600.1M | -37.5% |
| EPS (Basic) | -$3.58 | +7.3% |
| EPS (Diluted) | -$3.58 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $543.1M | -22.0% |
| Short-term Investments | $1.75B | +51.0% |
| Current Assets | $2.33B | +23.9% |
| Total Assets | $2.56B | +24.1% |
| Current Liabilities | $163.9M | +13.9% |
| Total Liabilities | $293.1M | +24.5% |
| Stockholders' Equity | $2.27B | +24.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$557.4M | -59.0% |
| Capital Expenditures | $10.3M | +33.4% |
| Investing Cash Flow | -$554.4M | -61.8% |
| Financing Cash Flow | $959.4M | -21.9% |
| Free Cash Flow | -$567.7M | -58.5% |
| +7.3% |